Emergent BioSolutions, Inc. (EBS)
6.22
+0.12
(+1.97%)
USD |
NYSE |
Sep 01, 16:00
6.21
-0.01
(-0.16%)
Pre-Market: 20:00
Emergent BioSolutions Net Income (TTM) : -176.80M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -176.80M |
| March 31, 2026 | -8.60M |
| December 31, 2025 | 52.60M |
| September 30, 2025 | 75.90M |
| June 30, 2025 | 139.50M |
| March 31, 2025 | -131.60M |
| December 31, 2024 | -190.60M |
| September 30, 2024 | -208.80M |
| June 30, 2024 | -587.00M |
| March 31, 2024 | -565.20M |
| December 31, 2023 | -760.40M |
| September 30, 2023 | -798.90M |
| June 30, 2023 | -622.60M |
| March 31, 2023 | -417.70M |
| December 31, 2022 | -235.20M |
| September 30, 2022 | 42.10M |
| June 30, 2022 | 96.50M |
| March 31, 2022 | 157.50M |
| December 31, 2021 | 230.90M |
| September 30, 2021 | 227.00M |
| June 30, 2021 | 299.20M |
| March 31, 2021 | 387.30M |
| December 31, 2020 | 305.10M |
| September 30, 2020 | 166.60M |
| June 30, 2020 | 170.30M |
| Date | Value |
|---|---|
| March 31, 2020 | 68.10M |
| December 31, 2019 | 54.60M |
| September 30, 2019 | 4.30M |
| June 30, 2019 | -17.96M |
| March 31, 2019 | 41.69M |
| December 31, 2018 | 62.78M |
| September 30, 2018 | 100.12M |
| June 30, 2018 | 112.73M |
| March 31, 2018 | 67.20M |
| December 31, 2017 | 82.59M |
| September 30, 2017 | 80.94M |
| June 30, 2017 | 67.78M |
| March 31, 2017 | 61.12M |
| December 31, 2016 | 62.52M |
| September 30, 2016 | 72.73M |
| June 30, 2016 | 94.43M |
| March 31, 2016 | 110.57M |
| December 31, 2015 | 77.16M |
| September 30, 2015 | 64.78M |
| June 30, 2015 | 44.53M |
| March 31, 2015 | 35.46M |
| December 31, 2014 | 36.74M |
| September 30, 2014 | 21.84M |
| June 30, 2014 | 13.50M |
| March 31, 2014 | 18.83M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Exelixis, Inc. | 860.62M |
| Capricor Therapeutics, Inc. | -129.42M |
| ADMA Biologics, Inc. | 168.96M |
| Akebia Therapeutics, Inc. | -29.67M |
| Arcutis Biotherapeutics, Inc. | 28.52M |